NM_145038.5:c.*9G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_145038.5(DRC1):​c.*9G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0612 in 1,613,910 control chromosomes in the GnomAD database, including 3,534 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 213 hom., cov: 33)
Exomes 𝑓: 0.063 ( 3321 hom. )

Consequence

DRC1
NM_145038.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.830

Publications

5 publications found
Variant links:
Genes affected
DRC1 (HGNC:24245): (dynein regulatory complex subunit 1) This gene encodes a central component of the nexin-dynein complex (N-DRC), which regulates the assembly of ciliary dynein. Mutations in this gene can cause ciliary dyskinesia. [provided by RefSeq, Aug 2015]
DRC1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 21
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 80
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-26456526-G-A is Benign according to our data. Variant chr2-26456526-G-A is described in ClinVar as [Benign]. Clinvar id is 262563.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.064 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC1NM_145038.5 linkc.*9G>A 3_prime_UTR_variant Exon 17 of 17 ENST00000288710.7 NP_659475.2 Q96MC2
DRC1XM_047446339.1 linkc.*9G>A 3_prime_UTR_variant Exon 10 of 10 XP_047302295.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DRC1ENST00000288710.7 linkc.*9G>A 3_prime_UTR_variant Exon 17 of 17 2 NM_145038.5 ENSP00000288710.2 Q96MC2
DRC1ENST00000649059.1 linkn.*1195G>A non_coding_transcript_exon_variant Exon 16 of 16 ENSP00000497543.1 A0A3B3IT12
DRC1ENST00000649059.1 linkn.*1195G>A 3_prime_UTR_variant Exon 16 of 16 ENSP00000497543.1 A0A3B3IT12

Frequencies

GnomAD3 genomes
AF:
0.0462
AC:
7038
AN:
152204
Hom.:
213
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0320
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0339
Gnomad ASJ
AF:
0.0412
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0244
Gnomad FIN
AF:
0.0312
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0657
Gnomad OTH
AF:
0.0435
GnomAD2 exomes
AF:
0.0436
AC:
10962
AN:
251272
AF XY:
0.0449
show subpopulations
Gnomad AFR exome
AF:
0.0321
Gnomad AMR exome
AF:
0.0243
Gnomad ASJ exome
AF:
0.0401
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.0341
Gnomad NFE exome
AF:
0.0651
Gnomad OTH exome
AF:
0.0480
GnomAD4 exome
AF:
0.0628
AC:
91745
AN:
1461590
Hom.:
3321
Cov.:
31
AF XY:
0.0613
AC XY:
44592
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.0286
AC:
956
AN:
33474
American (AMR)
AF:
0.0248
AC:
1110
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0403
AC:
1053
AN:
26128
East Asian (EAS)
AF:
0.00111
AC:
44
AN:
39696
South Asian (SAS)
AF:
0.0254
AC:
2186
AN:
86226
European-Finnish (FIN)
AF:
0.0375
AC:
2004
AN:
53420
Middle Eastern (MID)
AF:
0.0300
AC:
173
AN:
5760
European-Non Finnish (NFE)
AF:
0.0727
AC:
80814
AN:
1111794
Other (OTH)
AF:
0.0564
AC:
3405
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
4193
8385
12578
16770
20963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3000
6000
9000
12000
15000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0462
AC:
7039
AN:
152320
Hom.:
213
Cov.:
33
AF XY:
0.0433
AC XY:
3223
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0320
AC:
1329
AN:
41580
American (AMR)
AF:
0.0339
AC:
518
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0412
AC:
143
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5190
South Asian (SAS)
AF:
0.0244
AC:
118
AN:
4830
European-Finnish (FIN)
AF:
0.0312
AC:
331
AN:
10620
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0656
AC:
4463
AN:
68012
Other (OTH)
AF:
0.0435
AC:
92
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
342
683
1025
1366
1708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0563
Hom.:
533
Bravo
AF:
0.0463
Asia WGS
AF:
0.0140
AC:
53
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.43
DANN
Benign
0.93
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1054737; hg19: chr2-26679394; API